-
-
-
-
-
-
-
Capricor reports positive HOPE-3 trial results for Duchenne therapy
-
-
-
-
-
-
-
Celcuity Inc (CELC) PT Raised to $122 at Needham
-
-
-
-
-
-
-
Piper Sandler on Arvinas Inc. (ARVN): 'Multiple Data Readouts to Drive Value in 2026'
-
-
-
-
-
-
-
Jefferies Reiterates Buy Rating on Denali Therapeutics Inc. (DNLI)
-
-
-
-
-
-
-
KEYTRUDA Plus WELIREG Shows 28% Reduction in Cancer Recurrence Risk
-
-
-
-
-
-
-
argenx SE (ARGX) PT Lowered to $1,227 at Stifel
-
-
-
-
-
-
-
UBS Reiterates Buy Rating on Gilead Sciences (GILD) Following ACLX Acquisition Announcement
-
15,026 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

